FEATURES OF TREATMENT OF PERIODONTAL DISEASE IN CHILDREN WITH THYROID PATHOLOGY

The aim of the study is substantiation of reasonability to use macro- and trace element-containing medicines, glucosamine in the complex of treatment of chronic catarrhal gingivitis in children afflicted with diffuse nontoxic goiter. For this purpose clinical follow-up of 60 children aged 12 suffering from diffuse nontoxic goiter and chronic catarrhal gingivitis was conducted. The children were divided into two groups: the comparison group receiving generally excepted method of treatment, and the group of observation with the suggested improved method of treatment. The latter included additional general treatment including vitamin-mineral preparation “Calcemin advance” as well as glucosamine to eliminate deficiency of proteoglycan structural elements. “Calcemin advance” was administered in the dose of 1 tablet once a day while taking meals during 1 month twice a year. To eliminate glucosamine deficiency the medicine “Theraflex” was used according to the dose indicated: for children older than 12 – 1 capsule three times a day during 1 month followed by 1 capsule twice a day during 1 month while taking meals. The course of treatment was repeated twice a year. Conclusion. The use of the medicines “Calcemin advance” and “Theraflex” in the complex of treatment of chronic catarrhal gingivitis in children with diffuse nontoxic goiter was indicative of reduced terms of treatment and increased terms of remission. The results obtained give the reasons to recommend the use of these medicines with the aim to correct metabolism of the connective tissue complex in case of inflammatory diseases of the periodontal tissues in children with diffuse nontoxic goiter in particular. Considering the terms of relapses in the groups observed, repeated therapeutic-preventive courses are recommended with the frequency once in six months.